Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Compass Therapeutics shares are trading higher after Piper Sandler raised its price target on the stock from $4 to $6.

benzinga_article

Aug 7, 2026 at 06:28 PM

Compass Therapeutics shares are trading higher after Piper Sandler raised its price target on the stock from $4 to $6.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

Compass Therapeutics

USCMPX

+0.42%

Piper Sandler Cos

USPIPR

LongbridgeAI